Article
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases - Nature Biotechnology
Rating:
0.0
Views:
42
Likes:
1
Library:
1
The success of chimeric antigen receptor (CAR) T cell therapy in treating several hematopoietic malignancies has been difficult to replicate in solid tumors, in part because of T cell exhaustion and eventually dysfunction. To counter T cell dysfunction in the tumor microenvironment, we metabolically armored CAR T cells by engineering them to secrete interleukin-10 (IL-10).
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value